Search - tctmd.com

Displaying 561 - 580 of 6084

Sort: Relevancy | Date

Presentation THT 2024

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

Presenter: James W. Schurr

March 06, 2024

Presentation THT 2024

The Conundrum of Clinical Trials in Cardiogenic Shock

Presenter: JoAnn Lindenfeld

March 06, 2024

Presentation THT 2024

Introduction Of Guideline Directed Medical Therapy And Native Heart Recovery In Patients Supported By Impella 5.5

Presenter: Kanika P. Mody

March 06, 2024

Presentation THT 2024

The RECOVER IV Study Overview

Presenter: Navin K. Kapur

March 05, 2024

Presentation THT 2024

Pulmonary Artery Catheter in Shock (PACCS)

Presenter: Shashank Shekhar Sinha

March 05, 2024

Presentation THT 2024

ECMO-Unload: Is This the Answer to ECLS-SHOCK?

Presenter: Dirk Westermann

March 05, 2024

Presentation THT Abstracts 2024

Clinical Outcomes and the Impact of SCAI Stage among ProtekDuo Right Ventricular Assist Device Recipients with Cardiogenic Shock: A Report from the Cardiogenic Shock Working Group

Presenter: Kevin John

March 05, 2024

Presentation THT Abstracts 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presenter: Justin Fried

March 05, 2024

Presentation THT 2024

Inotropes and Mortality in Patients With Cardiogenic Shock Due to Myocardial Infarction: Insights from the SWEDEHEART Registry

Presenter: Elmir Omerovic

March 05, 2024

Presentation THT 2024

Deep Phenotyping in Cardiogenic Shock

Presenter: Song Li

March 05, 2024

Presentation THT 2024

Risk Stratification: Thinking Beyond SCAI Staging

Presenter: David A. Baran

March 05, 2024

Presentation THT 2024

Clinical Trials for Cardiogenic Shock: Going Forwards, Backwards, or Sideways?

Presenter: Mariell Jessup

March 05, 2024

Presentation THT 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presenter: Justin Fried

March 05, 2024

Presentation THT Abstracts 2024

The Clinical Effectiveness of Pulmonary Artery Catheter in Patients with Cardiogenic Shock

Presenter: Atsuyuki Watanabe

March 04, 2024

Presentation THT Abstracts 2024

Clinical Presentation, Management, and Outcomes of Patients with Intermediate Risk Acute Pulmonary Embolism and Normotensive Shock.

Presenter: Robert Zilinyi

March 04, 2024

Presentation THT 2024

Early Experience With Devices That Reduce Kidney Vascular Afterload From the Veins

Presenter: Ulrich P. Jorde

March 04, 2024

Presentation THT 2024

Early Experience With Devices That Increase Kidney Perfusion From the Aorta

Presenter: Jennifer A. Cowger

March 04, 2024

Presentation THT 2024

Mechanisms of Diuretic Resistance

Presenter: Jeffrey Testani

March 04, 2024

News Daily News

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

Todd Neale

March 04, 2024

News Daily News

DISCHARGE Data Reassure on Use of CCTA in Older Chest-Pain Patients

Michael O'Riordan

March 04, 2024

Advertisement

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

The Conundrum of Clinical Trials in Cardiogenic Shock

Introduction Of Guideline Directed Medical Therapy And Native Heart Recovery In Patients Supported By Impella 5.5

The RECOVER IV Study Overview

Pulmonary Artery Catheter in Shock (PACCS)

ECMO-Unload: Is This the Answer to ECLS-SHOCK?

Clinical Outcomes and the Impact of SCAI Stage among ProtekDuo Right Ventricular Assist Device Recipients with Cardiogenic Shock: A Report from the Cardiogenic Shock Working Group

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Inotropes and Mortality in Patients With Cardiogenic Shock Due to Myocardial Infarction: Insights from the SWEDEHEART Registry

Deep Phenotyping in Cardiogenic Shock

Risk Stratification: Thinking Beyond SCAI Staging

Clinical Trials for Cardiogenic Shock: Going Forwards, Backwards, or Sideways?

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

The Clinical Effectiveness of Pulmonary Artery Catheter in Patients with Cardiogenic Shock

Clinical Presentation, Management, and Outcomes of Patients with Intermediate Risk Acute Pulmonary Embolism and Normotensive Shock.

Early Experience With Devices That Reduce Kidney Vascular Afterload From the Veins

Early Experience With Devices That Increase Kidney Perfusion From the Aorta

Mechanisms of Diuretic Resistance

Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial

DISCHARGE Data Reassure on Use of CCTA in Older Chest-Pain Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content